Founded in 2004, Cadence Pharmaceuticals operates as a biopharmaceutical company. It offers various services that include development and commercialization of proprietary products for the health care industry. It offers therapeutic pharmaceuticals to hospitals for pain management, infectious disease, anesthesia and cardiology. It provides a wide range of services, including clinical development, regulatory approval, production and marketing. Cadence Pharmaceuticals manufactures Omnigard, a topical antimicrobial gel for the prevention and treatment of infections in surgical wounds, burns and medical injuries. The company has a research and development team that provides the data for its various projects, such as adult pharmacokinetic study.